CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 179 enrolled
Drug / intervention
Pharmaceutical care program for antidepressant treatmentbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00794196
NCT00794196N/ACompleted
CompareCT.gov

Impact of the Pharmaceutical Care Program for Pharmacological Treatment of Depression in Primary Care on the Compliance to Antidepressants and Patient Wellbeing

Fundació Sant Joan de Déu·interventional·Posted Nov 19, 2008·Updated Nov 22, 2016

In Brief

A clinical study evaluating Pharmaceutical care program for antidepressant treatment for Depression. Completed, enrolled 179 participants across 2 sites.

Detailed Summary

The purpose of this study is to evaluate the impact of pharmaceutical services among patients starting a treatment with antidepressants for a diagnosis of depression. The hypothesis of the study is that pharmacist intervention can improve compliance to antidepressants and patient wellbeing.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDepression
CountriesSpain
CollaboratorsCarlos III Health Institute, Catalan Institute of Health, University of Barcelona

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedNov 19, 2008
Enrollment StartOct 1, 2008
Primary CompletionNov 1, 2011
Study CompletionNov 1, 2012
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 17.6 years ago

Interventions

Pharmaceutical care program for antidepressant treatmentbehavioral

The pharmaceutical care program is a support program for patients starting and maintaining antidepressant treatment.